BCL2L12 and glioblastoma: For example, in one earlier study, they fabricated the RNAi-based SNA targeting oncogenes (Bcl2L12) which is traditionally untargetable by small molecules or antibodies in glioblastoma multiforme (GBM) pathogenesis [217].